Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New heart valve offers hope for patients too fragile for surgery
Disease control CompletedThis study tested a new, less invasive heart valve (CoreValve) in 782 people with severe aortic stenosis who were too sick for open-heart surgery. The goal was to see if the valve could safely reduce the risk of death or major stroke. The approach uses a catheter to place the val…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New heart valve shows promise in aortic stenosis patients
Disease control CompletedThis study tested a new heart valve called Evolut PRO in 638 people with a narrowed aortic valve (aortic stenosis). The valve was implanted to replace the diseased valve and help blood flow. The main goal was to see how many patients were alive 30 days after the procedure, and th…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New registry tracks device that anchors aneurysm grafts
Disease control CompletedThis study followed over 1,000 people who had or were getting a stent graft for an aortic aneurysm, using the Heli-FX EndoAnchor system to help secure the graft. The goal was to see how safe and effective the device is at preventing leaks and movement of the graft over 5 years. P…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC